The presumed atypical chemokine receptor CXCR7 signals through Gi/o proteins in primary rodent astrocytes and human glioma cells

GLIA

Volumn 60, Issue 3, 2012, Pages 372-381

  Ödemis, Veysel ^a   Lipfert, Jana ^a   Kraft, Robert ^b   Hajek, Peter ^c   Abraham, Getu ^c   Hattermann, Kirsten ^d   Mentlein, Rolf ^d   Engele, Jürgen ^a  

^a Institute of Anatomy   (Germany)

^b Carl Ludwig Institute for Physiology   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

Author keywords

CXCR4; G proteins; I TAC; SDF 1

Indexed keywords

BETA ARRESTIN; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; CXCL11 CHEMOKINE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PERTUSSIS TOXIN; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ARTICLE; ASTROCYTE; ASTROCYTOMA CELL; CALCIUM CELL LEVEL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GLIOMA CELL; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; RAT;

ANIMALS; ANIMALS, NEWBORN; ARRESTINS; ASTROCYTOMA; CALCIUM; CELL PROLIFERATION; CELLS, CULTURED; CEREBRAL CORTEX; CHEMOKINE CXCL12; CHEMOTAXIS; EMBRYO, MAMMALIAN; ENZYME INHIBITORS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; MICE; MICE, KNOCKOUT; NEUROGLIA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CXCR; RECEPTORS, CXCR4; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SULFUR ISOTOPES;

EID: 84856227953     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22271     Document Type: Article

References (57)

1. Bajetto A, Bonavia R, Barbero S, Piccioli P, Costa A, Florio T, Schettini G. 1999. Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J Neurochem 73: 2348-2357.
2. Bajetto A, Barbero S, Bonavia R, Piccioli P, Pirani P, Florio T, Schettini G. 2001. Stromal cell-derived factor-1alpha induces astrocyte proliferation through the activation of extracellular signal-regulated kinases 1/2 pathway. J Neurochem 77: 1226-1236.
3. Bajetto A, Barbieri F, Dorcaratto A, Barbero S, Daga A, Porcile C, Ravetti JL, Zona G, Spaziante R, Corte G, Schettini G, Florio T. 2006. Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: Role of CXCR4 and SDF1 in glioma cell proliferation and migration. Neurochem Int 49: 423-432.
4. Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B, Arenzana-Seisdedos F, Thelen M, Bachelerie F. 2005. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 280: 35760-35766.
5. Barbero S, Bonavia R, Bajetto A, Porcile C, Pirani P, Ravetti JL, Zona GL, Spaziante R, Florio T, Schettini G. 2003. Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 63: 1969-1974.
6. Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, Vescovi A, Bagetta G, Kollias G, Meldolesi J, Volterra A. 2001. CXCR4-activated astrocyte glutamate release via TNFalpha: Amplification by microglia triggers neurotoxicity. Nat Neurosci 4: 702-710.
7. Biber K, Dijkstra I, Trebst C, De Groot CJ, Ransohoff RM, Boddeke HW. 2002. Functional expression of CXCR3 in cultured mouse and human astrocytes and microglia. Neuroscience 112: 487-497.
8. Boldajipour B, Mahabaleshwar H, Kardash E, Reichman-Fried M, Blaser H, Minina S, Wilson D, Xu Q, Raz E. 2008. Control of chemokine-guided cell migration by ligand sequestration. Cell 132: 463-473.
9. Broxmeyer HE. 2008. Chemokines in hematopoiesis. Curr Opin Hematol 15: 49-58.
10. Buckingham M. 2006. Myogenic progenitor cells and skeletal myogenesis in vertebrates. Curr Opin Genet Dev 16: 525-532.
11. Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, Penfold ME, Sunshine MJ, Littman DR, Kuo CJ, Wei K, McMaster BE, Wright K, Howard MC, Schall TJ. 2006. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 203: 2201-2213.
12. Calatozzolo C, Canazza A, Pollo B, Di Pierro E, Ciusani E, Maderna E, Salce E, Sponza V, Frigerio S, Di Meco F, Schinelli S, Salmaggi A. 2011. Expression of the new CXCL12 receptor, CXCR7, in gliomas. Cancer Biol Ther 11: 242-253.
13. Cartier L, Hartley O, Dubois-Dauphin M, Krause KH. 2005. Chemokine receptors in the central nervous system: Role in brain inflammation and neurodegenerative diseases. Brain Res Brain Res Rev 48: 16-42.
14. Crump MP, Gong JH, Loetscher P, Rajarathnam K, Amara A, Arenzana-Seisdedos F, Virelizier JL, Baggiolini M, Sykes BD, Clark-Lewis I. 1997. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J 16: 6996-7007.
15. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK. 2007. Beta-arrestins and cell signaling. Annu Rev Physiol 69: 483-510.
16. do Carmo A, Patricio I, Cruz MT, Carvalheiro H, Oliveira CR, Lopes MC. 2010. CXCL12/CXCR4 promotes motility and proliferation of glioma cells. Cancer Biol Ther 9: 56-65.
17. Fumagalli M, Trincavelli L, Lecca D, Martini C, Ciana P, Abbracchio MP. 2004. Cloning, pharmacological characterisation and distribution of the rat G-protein-coupled P2Y(13) receptor. Biochem Pharmacol 68: 113-124.
18. Göttle P, Kremer D, Jander S, Odemis V, Engele J, Hartung HP, Küry P. 2010. Activation of CXCR7 receptor promotes oligodendroglial cell maturation. Ann Neurol 68: 915-924.
19. Goldberg SH, van der Meer P, Hesselgesser J, Jaffer S, Kolson DL, Albright AV, González-Scarano F, Lavi E. 2001. CXCR3 expression in human central nervous system diseases. Neuropathol Appl Neurobiol 27: 127-138.
20. Graham GJ. 2009. D6 and the atypical chemokine receptor family: Novel regulators of immune and inflammatory processes. Eur J Immunol 39: 342-351.
21. Grymula K, Tarnowski M, Wysoczynski M, Drukala J, Barr FG, Ratajczak J, Kucia M, Ratajczak MZ. 2010. Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas. Int J Cancer 127: 2554-2568.
22. Hatse S, Princen K, Bridger G, De Clercq E, Schols D. 2002. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett 527: 255-262.
23. Hattermann K, Held-Feindt J, Lucius R, Müerköster SS, Penfold ME, Schall TJ, Mentlein R. 2010. The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects. Cancer Res 70: 3299-3308.
24. Kalatskaya I, Berchiche YA, Gravel S, Limberg BJ, Rosenbaum JS, Heveker N. 2009. AMD3100 is a CXCR7 ligand with allosteric agonist properties. Mol Pharmacol 75: 1240-1247.
25. Lazarini F, Casanova P, Tham TN, De Clercq E, Arenzana-Seisdedos F, Baleux F, Dubois-Dalcq M. 2000. Differential signalling of the chemokine receptor CXCR4 by stromal cell-derived factor 1 and the HIV glycoprotein in rat neurons and astrocytes. Eur J Neurosci 12: 117-125.
26. Levoye A, Balabanian K, Baleux F, Bachelerie F, Lagane B. 2009. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 113: 6085-6093.
27. Li M, Ransohoff RM. 2008. Multiple roles of chemokine CXCL12 in the central nervous system: A migration from immunology to neurobiology. Prog Neurobiol 84: 116-131.
28. Luker KE, Gupta M, Steele JM, Foerster BR, Luker GD. 2009. Imaging ligand-dependent activation of CXCR7. Neoplasia 11: 1022-1035.
29. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA. 1998. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA 95: 448-9453.
30. Miao Z, Luker KE, Summers BC, Berahovich R, Bhojani MS, Rehemtulla A, Kleer CG, Essner JJ, Nasevicius A, Luker GD, Howard MC, Schall TJ. 2007. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci USA 104: 15735-15740.
31. Naumann U, Cameroni E, Pruenster M, Mahabaleshwar H, Raz E, Zerwes HG, Rot A, Thelen M. 2010. CXCR7 functions as a scavenger for CXCL12 and CXCL11. PLoS One 5: e9175.
32. Ödemis V, Boosmann K, Dieterlen MT, Engele J. 2007. The chemokine SDF1 controls multiple steps of myogenesis through atypical PKCzeta. J Cell Sci 120: 4050-4059.
33. Ödemis V, Boosmann K, Heinen A, Küry P, Engele J. 2010. CXCR7 is an active component of SDF-1 signalling in astrocytes and Schwann cells. J Cell Sci 123: 1081-1088.
34. Ödemis V, Lamp E, Pezeshki G, Moepps B, Schilling K, Gierschik P, Littman DR, Engele J. 2005. Mice deficient in the chemokine receptor CXCR4 exhibit impaired limb innervation and myogenesis. Mol Cell Neurosci 30: 494-505.
35. Ödemis V, Moepps B, Gierschik P, Engele J. 2002. Interleukin-6 and cAMP induce stromal cell-derived factor-1 chemotaxis in astroglia by up-regulating CXCR4 cell surface expression. Implications for brain inflammation. J Biol Chem 277: 39801-39808.
36. Rajagopal S, Kim J, Ahn S, Craig S, Lam CM, Gerard NP, Gerard C, Lefkowitz RJ. 2010a. Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7. Proc Natl Acad Sci USA 107: 628-632.
37. Rajagopal S, Rajagopal K, Lefkowitz RJ. 2010b. Teaching old receptors new tricks: Biasing seven-transmembrane receptors. Nat Rev Drug Discov 9: 373-386.
38. Rempel SA, Dudas S, Ge S, Gutiérrez JA. 2000. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 6: 102-111.
39. Reuss B, von Bohlen und Halbach O. 2003. Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res 313: 139-157.
40. Rostène W, Kitabgi P, Parsadaniantz SM. 2007. Chemokines: A new class of neuromodulator? Nat Rev Neurosci 8: 895-903.
41. Schönemeier B, Kolodziej A, Schulz S, Jacobs S, Hoellt V, Stumm R. 2008a. Regional and cellular localization of the CXCl12/SDF-1 chemokine receptor CXCR7 in the developing and adult rat brain. J Comp Neurol 510: 207-220.
42. Schönemeier B, Schulz S, Hoellt V, Stumm R. 2008b. Enhanced expression of the CXCl12/SDF-1 chemokine receptor CXCR7 after cerebral ischemia in the rat brain. J Neuroimmunol 198: 39-45.
43. Sierro F, Biben C, Martínez-Muñoz L, Mellado M, Ransohoff RM, Li M, Woehl B, Leung H, Groom J, Batten M, Harvey RP, Martínez AC, Mackay CR, Mackay F. 2007. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci USA 104: 14759-14764.
44. Subileau EA, Rezaie P, Davies HA, Colyer FM, Greenwood J, Male DK, Romero IA. 2009. Expression of chemokines and their receptors by human brain endothelium: Implications for multiple sclerosis. J Neuropathol Exp Neurol 68: 227-240.
45. Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y, Kitamura Y, Matsushima K, Yoshida N, Nishikawa S, Kishimoto T, Nagasawa T. 1998. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393: 591-594.
46. Tanabe S, Heesen M, Yoshizawa I, Berman MA, Luo Y, Bleul CC, Springer TA, Okuda K, Gerard N, Dorf ME. 1997. Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes. J Immunol 159: 905-911.
47. Tanuma N, Sakuma H, Sasaki A, Matsumoto Y. 2006. Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis. Acta Neuropathol 112: 195-204.
48. Thelen M, Thelen S. 2008. CXCR7, CXCR4 and CXCL12: An eccentric trio? J Neuroimmunol 198: 9-13.
49. Tonazzini I, Trincavelli ML, Storm-Mathisen J, Martini C, Bergersen LH. Co-localization and functional cross-talk between A1 and P2Y1 purine receptors in rat hippocampus. 2007. Eur J Neurosci 26: 890-902.
50. Tran PB, Banisadr G, Ren D, Chenn A, Miller RJ. 2007. Chemokine receptor expression by neural progenitor cells in neurogenic regions of mouse brain. J Comp Neurol 500: 1007-1033.
51. Trincavelli ML, Melani A, Guidi S, Cuboni S, Cipriani S, Pedata F, Martini C. 2008. Regulation of A(2A) adenosine receptor expression and functioning following permanent focal ischemia in rat brain. J Neurochem 104: 479-490.
52. Wang J, Shiozawa Y, Wang J, Wang Y, Jung Y, Pienta KJ, Mehra R, Loberg R, Taichman RS. 2008. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem 283: 4283-4294.
53. Wang Y, Li G, Stanco A, Long JE, Crawford D, Potter GB, Pleasure SJ, Behrens T, Rubenstein JL. 2011. CXCR4 and CXCR7 have distinct functions in regulating interneuron migration. Neuron 69: 61-76.
54. Zabel BA, Wang Y, Lewén S, Berahovich RD, Penfold ME, Zhang P, Powers J, Summers BC, Miao Z, Zhao B, Jalili A, Janowska-Wieczorek A, Jaen JC, Schall TJ. 2009. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J Immunol 183: 3204-3211.
55. Zagzag D, Lukyanov Y, Lan L, Ali MA, Esencay M, Mendez O, Yee H, Voura EB, Newcomb EW. 2006. Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: Implications for angiogenesis and glioma cell invasion. Lab Invest 86: 1221-1232.
56. Zhou Y, Larsen PH, Hao C, Yong VW. 2002. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 277: 49481-49487.
57. Zou Y-R, Kottmann AH, Kurado M, Taniuchi I, Littman DR. 1998. Function of the chemokine receptor CXCR4 in hematopoiesis and in cerebellar development. Nature 393: 595-599.